Table 2 Distribution of study participants by blood pressure variables (n = 112)
Blood pressure variable | n (%) |
|---|---|
Duration since diagnosed with blood pressure (years), Median (IQR) | 4.5 (2–10) |
Routine care, n (%) | |
Yes | 45 (40.2) |
Frequency of review, n (%) | |
Not reviewed | 64 (57.1) |
Monthly | 32 (28.6) |
Every 2 months | 6 (5.4) |
Every 3 months | 10 (8.9) |
Current treatment for hypertension, n (%) | |
Yes | 53 (47.3) |
Drugs participant uses for blood pressure, n (%) | |
Calcium channel blockers | 43 (39.1) |
Diuretics | 14 (12.7) |
Β-blockers | 15 (13.6) |
ACEIs/ARBs | 37 (33.6) |
Alpha–adrenergic agonist (methyldopa) | 1 (1) |
Drug therapy, n (%) | |
Mono-therapy | 16 (28.1) |
Duo-therapy | 33 (57.9) |
Multi-therapy | 8 (14.0) |
Lipid lowering therapy, n (%) | |
Yes | 3 (2.6) |
Herbal medication, n (%) | |
Yes | 37 (33.0) |
Family history of hypertension, n (%) | |
Yes | 59 (52.7) |
Challenges experienced on drugs, n (%) | |
Cost | 47 (42.3) |
Access | 9 (8.1) |
Side effects | 4 (3.6) |
Pill load | 3 (2.7) |
None | 45 (40.5) |
Previous diagnosis of diabetes mellitus, n (%) | |
Yes | 24 (21.4) |
Currently on medication for diabetes, n (%) | |
Yes | 21 (87.5) |
Level of control for sugar, n (%) | |
Good | 20 (95.2) |
Poor | 1 (4.8) |